Multiple sclerosis patients and COVID-19

被引：0
|
作者：
Hubert Mado
Monika Adamczyk-Sowa
机构：
[1] Medical University of Silesia in Katowice,Department of Neurology, Faculty of Medical Sciences in Zabrze
[2] Poland,undefined
来源：
The Egyptian Journal of Neurology, Psychiatry and Neurosurgery | / 57卷
关键词：
Multiple sclerosis; MS; COVID-19; SARS-CoV-2; DMT;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Coronavirus disease 2019 (COVID-19) is now a major issue for all fields of medicine. Due to the higher mortality rate among patients with chronic diseases, it has also caused concern in patients with multiple sclerosis (MS), who in addition are often receiving immunosuppressive drugs. The aim of this article is to discuss what is currently known about the severity of COVID-19 in MS patients.
引用
收藏
相关论文
共 50 条
  • [41] IMPACT OF MULTIPLE SCLEROSIS ON MORTALITY OF CRITICALLY ILL PATIENTS WITH COVID-19
    Reyes, Laura Gonzalez
    Garza, John
    Ucar, Rumeysa
    Ali, Alishah Akbar
    Singh, Trisha
    Khair, Ali Hamza
    Oud, Lavi
    CRITICAL CARE MEDICINE, 2025, 53 (01)
  • [42] Could Fampridine Attenuate the Severity of COVID-19 in Patients with Multiple Sclerosis?
    Moghadasi, Abdorreza Naser
    Anjidani, Nassim
    Rashvand, Fereshteh
    FRONTIERS IN EMERGENCY MEDICINE, 2021, 5 (03):
  • [43] COVID-19 infection and vaccination in multiple sclerosis patients in bogota, colombia
    Enriquez Ruano, Pilar
    Guio-Sanchez, Claudia
    Lopez-Reyes, Lorena
    Cardenas Robledo, Simon
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (02) : NP32 - NP32
  • [44] COVID-19 Vaccines Are Not Associated With Axonal Damage In Patients With Multiple Sclerosis
    Sainz De La Maza, Susana
    Rodero Romero, Alexander
    Monreal, Enric
    Chico Garcia, Juan Luis
    Villarrubia, Noelia
    Rodriguez Jorge, Fernando
    Fernandez Velasco, Jose Ignacio
    Sainz Amo, Raquel
    Masjuan, Jaime
    Costa-Frossard, Lucienne
    Maria Villar, Luisa
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 969 - 970
  • [45] The Safety Profile of Common COVID-19 Vaccines in Patients With Multiple Sclerosis
    Aladdin, Yasser S.
    Alqarni, Danah A.
    Alamoudi, Sheifa W.
    Alharbi, Abdulrahman A.
    Fudhah, Waad A.
    Alghamdi, Ghaida
    Attar, Ahmed
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (02)
  • [46] Investigation of fatigue and anxiety in patients with multiple sclerosis during COVID-19
    Bilek, Furkan
    Balgetir, Ferhat
    Demir, Caner
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429
  • [47] Multiple sclerosis patients' response to COVID-19 pandemic and vaccination in Egypt
    Gad, Adel Hassanein Elsayed
    Ahmed, Sandra Mohamed
    Garadah, Mostafa Yahya Abdelmohsen
    Dahshan, Ahmed
    EGYPTIAN JOURNAL OF NEUROLOGY PSYCHIATRY AND NEUROSURGERY, 2022, 58 (01):
  • [48] Multiple sclerosis patients' response to COVID-19 pandemic and vaccination: correspondence
    Mungmunpuntipantip, Rujittika
    Wiwanitkit, Viroj
    EGYPTIAN JOURNAL OF NEUROLOGY PSYCHIATRY AND NEUROSURGERY, 2023, 59 (01):
  • [49] Treatment with natalizumab during the Covid-19 pandemic in multiple sclerosis patients
    Diaz-Diaz, Judit
    Isabel Ramirez, Clara
    Ortiz-Pica, Marta
    Garcia-Yusta, Elena
    Gomez-Estevez, Irene
    Oreja-Guevara, Celia
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429
  • [50] Risk and outcomes of COVID-19 in patients with multiple sclerosis in Madrid Spain
    Moreno-Torres, I.
    Meca-Lallana, V.
    Costa-Frossard, L.
    Oreja-Guevara, C.
    Aguirre, C.
    Alba Suarez, E.
    Gomez Moreno, M.
    Borrega Canelo, L.
    Sabin-Munoz, J.
    Aladro, Y.
    Carcamo Fonfria, A.
    Rodriguez Garcia, E.
    Cuello, J. P.
    Monreal, E.
    Sainz De La Maza, S.
    Perez Parra, F.
    Valenzuela, F. J.
    Lopez De Silanes, C.
    Casanova Peno, L. I.
    Martinez-Gines, M. L.
    Blasco Quilez, M. R.
    Orviz Garcia, A.
    Villar, L. M.
    Santiuste, C.
    Espino, M.
    Fernandez-Dono, G.
    Elvira, V.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 60 - 60
12345